We are live on
!
Find out more
CCA
Catalyst Capital Advisors Portfolio holdings
AUM
$6.03B
1-Year Est. Return
24.5%
This Fund
S&P 500
This Quarter
Est. Return
+2.73%
1 Year Est. Return
+24.5%
3 Year Est. Return
+62.66%
5 Year Est. Return
+62.45%
10 Year Est. Return
+241.55%
AUM
$872M
AUM Growth
+$19.8M
(+2.3%)
Cap. Flow
+$16.5M
Cap. Flow
% of AUM
1.89%
Top 10 Holdings %
Top 10 Hldgs %
18.4%
Holding
619
New
128
Increased
115
Reduced
79
Closed
181
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$20.3M |
| 2 |
Delta Air Lines
DAL
|
+$16.9M |
| 3 |
S
Sprint Corporation
S
|
+$15.9M |
| 4 |
Enovis
ENOV
|
+$14.7M |
| 5 |
SWN
Southwestern Energy Company
SWN
|
+$13.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bausch Health
BHC
|
+$21.7M |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$19.8M |
| 3 |
Flex
FLEX
|
+$17.9M |
| 4 |
Synchrony
SYF
|
+$15.3M |
| 5 |
Boston Scientific
BSX
|
+$14.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.85% |
| 2 | Industrials | 13.14% |
| 3 | Consumer Discretionary | 12.72% |
| 4 | Technology | 12.14% |
| 5 | Energy | 10.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HEES
126
DELISTED
H&E Equipment Services
HEES
| $1.31M | 0.15% |
52,500
+32,500
| +163% | +$731K |
|
127
Johnson & Johnson
JNJ
$635B
| $1.3M | 0.15% |
12,900
+1,000
| +8% | +$102K |
|
128
Molson Coors Class B
TAP
$7.68B
| $1.29M | 0.15% |
17,300
-2,000
| -10% | -$151K |
|
|
TSYS
129
DELISTED
TELECOMMUNICATIONS SYS INC "A"
TSYS
| $1.29M | 0.15% |
335,862
| – | – |
|
|
RDS.A
130
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $1.28M | 0.15% |
21,500
+6,500
| +43% | +$412K |
|
|
LNCE
131
DELISTED
Snyders-Lance, Inc.
LNCE
| $1.27M | 0.15% |
39,871
| – | – |
|
|
MR
132
DELISTED
Montage Resources Corporation Common Stock
MR
| $1.26M | 0.15% |
15,000
+8,333
| +125% | +$795K |
|
|
JMP
133
DELISTED
JMP Group LLC
JMP
| $1.26M | 0.14% |
150,000
+15,000
| +11% | +$116K |
|
134
SunCoke Energy
SXC
$757M
| $1.2M | 0.14% |
+80,000
| New | +$1.37M |
|
|
EXL
135
DELISTED
EXCEL TRUST , INC COM STK
EXL
| $1.19M | 0.14% |
85,000
| – | – |
|
136
Kratos Defense & Security Solutions
KTOS
$8.88B
| $1.17M | 0.13% |
211,953
| – | – |
|
|
POT
137
DELISTED
Potash Corp Of Saskatchewan
POT
| $1.16M | 0.13% |
36,000
-4,000
| -10% | -$141K |
|
138
Vodafone
VOD
$34.9B
| $1.15M | 0.13% |
35,090
| – | – |
|
139
Ingredion
INGR
$6.38B
| $1.09M | 0.13% |
14,000
-5,800
| -29% | -$475K |
|
140
Verastem
VSTM
$532M
| $1.07M | 0.12% |
8,750
+6,667
| +320% | +$699K |
|
141
Crocs
CROX
$6.69B
| $1.06M | 0.12% |
90,000
-35,000
| -28% | -$392K |
|
|
BLPH
142
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
| $1.06M | 0.12% |
+7,667
| New | +$1.19M |
|
|
DISCK
143
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
| $1.03M | 0.12% |
+35,000
| New | +$1.06M |
|
144
Lands' End
LE
$361M
| $1.02M | 0.12% |
28,500
-45,000
| -61% | -$1.79M |
|
145
Bruker
BRKR
$9.2B
| $1.02M | 0.12% |
+55,000
| New | +$1.04M |
|
|
FBC
146
DELISTED
Flagstar Bancorp, Inc. New
FBC
| $1.02M | 0.12% |
70,000
-20,000
| -22% | -$299K |
|
147
HP
HPQ
$23.5B
| $1.01M | 0.12% |
71,565
-283,184
| -80% | -$4.67M |
|
148
Tidewater
TDW
$3.91B
| $1M | 0.12% |
1,628
+465
| +40% | +$414K |
|
149
FIVE9
FIVN
$1.77B
| $1M | 0.11% |
+180,200
| New | +$781K |
|
150
BP
BP
$113B
| $997K | 0.11% |
30,733
| – | – |
|
Similar funds
RCG
WHRC
EAM
AAM
CM
HPG
EMPI
GA
Catalyst Capital Advisors's Q1 2015 Portfolio in Review
As of Q1 2015, Catalyst Capital Advisors held 619 positions worth $872M, up 2.3% from $852M the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Catalyst Capital Advisors's Q1 2015 filing shows 128 new, 115 increased, 79 reduced and 181 closed positions. Its largest new stake was Alnylam Pharmaceuticals: 200,250 shares worth $20.9M. The largest sale was Bausch Health, an estimated $21.7M.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, down from 15% a quarter earlier, followed by Industrials and Consumer Discretionary.
- Catalyst Capital Advisors's largest Q1 2015 buy was Alnylam Pharmaceuticals: 200,250 shares worth $20.9M.
- Catalyst Capital Advisors added most to Delta Air Lines in Q1 2015, an estimated $16.9M increase.
- Catalyst Capital Advisors's biggest Q1 2015 reduction was Bausch Health, cutting an estimated $21.7M.
- Catalyst Capital Advisors fully exited COVIDIEN PLC COM SHS NEW (IRELAND) in Q1 2015, selling an estimated $19.8M.
- Catalyst Capital Advisors's ten largest holdings make up 18% of its $872M portfolio in Q1 2015.
- Catalyst Capital Advisors opened 128 new positions and closed 181 in Q1 2015.
- Catalyst Capital Advisors's portfolio value rose 2.3% quarter-over-quarter to $872M.
Based on Catalyst Capital Advisors's 13F filing for Q1 2015, filed 15 May 2015.